Table 2.
Mechanisms of reduced 6-min walk distance after COVID-19 illness.
Unadjusted analysis |
Adjusted analysis |
||||||||
---|---|---|---|---|---|---|---|---|---|
Model | Outcome | Primary predictor(s) | Coefficient | 95%CI | P-value | Coefficient | 95%CI | P-value | Prespecified covariates |
1a | 6MWD | BORG dyspnea | −22 | −33, −12 | <0.001 | −17 | −27, −8 | <0.001 | Age, sex, smoker, BMI, timea |
1b | 6MWD | BORG fatigue | −5 | −13, 4 | 0.277 | −4 | −11, 4 | 0.298 | Age, sex, smoker, BMI, time |
1c | 6MWD | End-exercise SpO2 | 8 | 4, 11 | <0.001 | 8 | 4, 12 | <0.001 | Age, sex, smoker, BMI, time |
2 | 6MWD | BORG dyspnea | −18 | −29, −7 | <0.001 | −13 | −22, −3 | 0.009 | Age, sex, smoker, BMI, time |
End-exercise SpO2 | 6 | 2, 10 | 0.004 | 7 | 3, 10 | <0.001 |
Abbreviations: 6MWD, 6-min walk distance; BMI, body mass index; CI, confidence interval, SpO2, oxygen saturation by pulse oximetry.
Time from symptom onset.